These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16265208)

  • 1. Obesity and visceral fat: a growing inflammatory disease.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):245. PubMed ID: 16265208
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biology of visceral fat].
    Klöting N; Stumvoll M; Blüher M
    Internist (Berl); 2007 Feb; 48(2):126-33. PubMed ID: 17216235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.
    Wolf D; Jehle F; Michel NA; Bukosza EN; Rivera J; Chen YC; Hoppe N; Dufner B; Rodriguez AO; Colberg C; Nieto L; Rupprecht B; Wiedemann A; Schulte L; Peikert A; Bassler N; Lozhkin A; Hergeth SP; Stachon P; Hilgendorf I; Willecke F; von Zur Mühlen C; von Elverfeldt D; Binder CJ; Aichele P; Varo N; Febbraio MA; Libby P; Bode C; Peter K; Zirlik A
    Circulation; 2014 Jun; 129(23):2414-25. PubMed ID: 24664276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity as a link between obesity and insulin resistance.
    Kalupahana NS; Moustaid-Moussa N; Claycombe KJ
    Mol Aspects Med; 2012 Feb; 33(1):26-34. PubMed ID: 22040698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice.
    Maioli TU; Gonçalves JL; Miranda MC; Martins VD; Horta LS; Moreira TG; Godard AL; Santiago AF; Faria AM
    Inflamm Res; 2016 Feb; 65(2):169-78. PubMed ID: 26650032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement factor C3 in lipid metabolism.
    Barbu A; Hamad OA; Lind L; Ekdahl KN; Nilsson B
    Mol Immunol; 2015 Sep; 67(1):101-7. PubMed ID: 25746915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):103-11. PubMed ID: 16265128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.
    Klimcáková E; Roussel B; Márquez-Quiñones A; Kovácová Z; Kováciková M; Combes M; Siklová-Vítková M; Hejnová J; Srámková P; Bouloumié A; Viguerie N; Stich V; Langin D
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E73-82. PubMed ID: 21047918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.
    Maury E; Brichard SM
    Mol Cell Endocrinol; 2010 Jan; 314(1):1-16. PubMed ID: 19682539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects.
    Saijo Y; Kiyota N; Kawasaki Y; Miyazaki Y; Kashimura J; Fukuda M; Kishi R
    Diabetes Obes Metab; 2004 Jul; 6(4):249-58. PubMed ID: 15171748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women.
    Schoen RE; Schragin J; Weissfeld JL; Thaete FL; Evans RW; Rosen CJ; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):581-6. PubMed ID: 12050100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity and immune function].
    D'Orazio N
    Ann Ital Chir; 2005; 76(5):413-6. PubMed ID: 16696213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
    Alam I; Lewis K; Stephens JW; Baxter JN
    Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video).
    Xia L; Hua J; Dray X; Khashab MA; Liang S; Kim YS; Jimeno-Ayllon C; Kalloo AN; Li Z
    Gastrointest Endosc; 2011 Sep; 74(3):637-44. PubMed ID: 21872714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transgenic model of visceral obesity and the metabolic syndrome.
    Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
    Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology of Adipose Tissue during Metabolic Syndrome.
    Ghazarian M; Luck H; Revelo XS; Winer S; Winer DA
    Turk Patoloji Derg; 2015; 31 Suppl 1():172-80. PubMed ID: 26177326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.